期刊文献+

动静脉内瘘闭塞的原因探讨及防治 被引量:7

下载PDF
导出
摘要 目的:探讨血液透析患者动静脉内瘘(AVF)闭塞的原因及如何预防、治疗。方法:对91例建立永久性AVF并行维持性血液透析患者进行回顾性分析。发生栓塞者分别行内瘘动脉端注入尿激酶或肝素及导管介入下溶栓。结果:发现21例AVF闭塞,其中原发病为糖尿病患者10例,穿刺不当及压迫时间过长者5例,低血压者4例,心动过缓1例,促红素未及时减量者1例。其中8例发现栓塞<12 h,予溶栓治疗后5例再通。结论:AVF闭塞与糖尿病,瘘口压迫时间过长,内瘘穿刺不当,血液黏滞度增加,透析中低血压等因素有关,尽早发现内瘘闭塞及尽早行溶栓治疗是再通的关键。
出处 《中国中西医结合肾病杂志》 2014年第11期1004-1005,共2页 Chinese Journal of Integrated Traditional and Western Nephrology
  • 相关文献

参考文献11

二级参考文献56

  • 1刘明辉,周启昌,刘启明,范平,申可佳,张轶.彩色多普勒超声引导压迫治疗假性动脉瘤[J].中华超声影像学杂志,2005,14(5):393-394. 被引量:15
  • 2张训.老年人血液透析的几个问题[J].中华肾脏病杂志,1995,11(6):367-368. 被引量:54
  • 3NKF-K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendation 2006:Updates:Vasoular Acuss,AJKD,2006,48:s1-s322.
  • 4Roy-Chaudhury P,Sukhatme VP,Cheng AK.Hemodialysis vascular access dysfunction:a cellular and molecular viewpoint.J Am Soc Nephrol,2006,17(4):1112-1127.
  • 5Beathard GA,Arnold P,Jackson J,et al.Aggressive treatment of early fistula failure.Kidney Int,2004,66(3):1289.
  • 6Song I,Yang W,Kim S,et al.Association of Plasma Fibrinogen Concentration with Vascular Acess Failure in Hemodialysis Patients.Nephrol Dial Transplant,1999,14:137-141.
  • 7Henricus J,Huijbregts TAM,Michiel L,et al.Hospital specific aspects predominantly determine primary failure of hemodialysis arteriovenous fistulas.J of Vas Surg,2007,41(4):286-288.
  • 8Paum M,Beach K,Ahmad S,et al.New ultrasound approaches to dialysis access monitoring.Am J Kidney Dis,2000,35(3):477-481.
  • 9Asif A,Gadalean FN,Mereill D,et al.Inflow stenosis in arteriovenous fistulas and grafts:a multicenter,prospective study.Kidney Int,2005,67(5):1986-1992.
  • 10Miller PE,Tolwani A,Luscy CP,et al.Predictors of adequacy of arteriovenous fistulas in hemodialysis patients.Kidney Int,1999,56(1):275-280.

共引文献127

同被引文献56

  • 1孙懿,刘惠兰.血液透析患者动静脉内瘘动脉瘤形成的原因及预防措施[J].中国血液净化,2005,4(1):29-31. 被引量:44
  • 2刘春来,刘锁民,刘屹立,王平.尿激酶治疗血液透析患者动静脉内瘘血栓形成的临床体会[J].疑难病杂志,2006,5(3):198-199. 被引量:8
  • 3郁正亚,谭正力.透析用血管通路建立手册[M].北京:人民卫生出版社,2012.167.
  • 4Sehgal A R, Dor A, Tsai A C. Morbidity and cost impli- cations of inadequate hemodialysis[ J]. Am J Kidney Dis, 2001,37 ( 6 ) : 1223-1231.
  • 5Vascular Access Work Group. Clinical practice guidelines for vascular access[ J]. Am J Kidney Dis, 2006,48 (Sup- pl 1 ) :S248-S273.
  • 6Weng F L, Berns J S. Complications of percutaneous treatment of thrombosed hemodialysis access grafts [ J ]. Semin Dial, 2003,16 ( 3 ) : 257-262.
  • 7Young A T, Hunter D W, Castaneda Zuniga W R, et al. Thrombosed synthetic hemodialysis access fistulas: failure of fibrinolytic therapy [ J ]. Radiology, 1985, 154 ( 3 ) : 639 -642.
  • 8Falk A, Harbour K. Tenecteplase in the treatment of thrombosed hemodialysis grafts [ J ]. Cardiovasc Intervent Radiol, 2005,28(4) :472-475.
  • 9van der Merwe E, Luscombe R, Kiaii M. The use of tissue plasminogen activator as continuous infusion into an arteri- ovenous hemodialysis access in the hemodialysis unit: a case series[J]. Can J Kidney Health Dis, 2015,2:2.
  • 10王文娟,吴春燕,应迎娟,王国红,倪虹,莫华利,叶有新.穿刺方法对血透动静脉内瘘并发症的影响[J].中华护理杂志,2009,44(2):180-181. 被引量:171

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部